WHO recommends second malaria vaccine, hoping to address supply issues
Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second, seeking to broaden access to a tool it hopes can save lives.
The vaccine, called R21/Matrix-M, was developed by the University of Oxford and will be produced by the Serum Institute of India, the world’s largest vaccine manufacturer.
Read Original Article: WHO recommends second malaria vaccine, hoping to address supply issues »
